Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study

Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the phys...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Medical Directors Association 2017-10, Vol.18 (10), p.848-852
Hauptverfasser: Rolland, Yves, MD, PhD, Dupuy, Charlotte, PhD, Abellan Van Kan, Gabor, MD, PhD, Cesari, Matteo, MD, PhD, Vellas, Bruno, MD, PhD, Faruch, Marie, MD, Dray, Cedric, MD, PhD, de Souto Barreto, Philipe, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 852
container_issue 10
container_start_page 848
container_title Journal of the American Medical Directors Association
container_volume 18
creator Rolland, Yves, MD, PhD
Dupuy, Charlotte, PhD
Abellan Van Kan, Gabor, MD, PhD
Cesari, Matteo, MD, PhD
Vellas, Bruno, MD, PhD
Faruch, Marie, MD
Dray, Cedric, MD, PhD
de Souto Barreto, Philipe, PhD
description Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance.
doi_str_mv 10.1016/j.jamda.2017.05.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1911701433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525861017302773</els_id><sourcerecordid>1911701433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</originalsourceid><addsrcrecordid>eNqFkUtv1DAUhSNERR_wC5CQl2wS_BjbCRJIo1EfSJUoBMTS8tg3qkMSD3aClH9fmyks2HTluzjnHp_vFsVrgiuCiXjXV70era4oJrLCvMIEPyvOCGd12TDJn-eZ8rIWBJ8W5zH2GCdpI14Up7QWtJFEnhWx1cH4A0xOo9YEgAks2q9ovgfUbr_uyiv0ZYE4Oz9N2gVAerLo7n6NzugB3UHofBj1ZCAi36HLwUIYVvTDjzC9R1u0Cz7GsgWTFyRDOy92fVmcdHqI8OrxvSi-X11-292Ut5-vP-22t6XZ1HguDeaNYEzTuu5EzQ0HYTnjrOm6De5qSwVIJsieYQFUEttJymq9x1QLwxtg7KJ4e9x7CP5XLqFGFw0Mg57AL1GRhhCJyYZlKTtKTf5wgE4dght1WBXBKtNWvfpDW2XaCnOVaCfXm8eAZT-C_ef5izcJPhwFkGr-dhBUNA4SLZtQmllZ754I-Pif3wxuyuh_wgqx90tIVFMTFanCqs0Hz_dO0ZhKydgDa3WlSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1911701433</pqid></control><display><type>article</type><title>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Rolland, Yves, MD, PhD ; Dupuy, Charlotte, PhD ; Abellan Van Kan, Gabor, MD, PhD ; Cesari, Matteo, MD, PhD ; Vellas, Bruno, MD, PhD ; Faruch, Marie, MD ; Dray, Cedric, MD, PhD ; de Souto Barreto, Philipe, PhD</creator><creatorcontrib>Rolland, Yves, MD, PhD ; Dupuy, Charlotte, PhD ; Abellan Van Kan, Gabor, MD, PhD ; Cesari, Matteo, MD, PhD ; Vellas, Bruno, MD, PhD ; Faruch, Marie, MD ; Dray, Cedric, MD, PhD ; de Souto Barreto, Philipe, PhD</creatorcontrib><description>Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance.</description><identifier>ISSN: 1525-8610</identifier><identifier>EISSN: 1538-9375</identifier><identifier>DOI: 10.1016/j.jamda.2017.05.010</identifier><identifier>PMID: 28629717</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Cross-Sectional Studies ; Female ; France - epidemiology ; Geriatric Assessment ; Hand Strength ; Humans ; Internal Medicine ; Medical Education ; physical performances ; SARC-F ; Sarcopenia ; Sarcopenia - diagnosis ; Sarcopenia - epidemiology ; screening ; Surveys and Questionnaires ; Walking Speed</subject><ispartof>Journal of the American Medical Directors Association, 2017-10, Vol.18 (10), p.848-852</ispartof><rights>AMDA – The Society for Post-Acute and Long-Term Care Medicine</rights><rights>2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine</rights><rights>Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</citedby><cites>FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jamda.2017.05.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28629717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rolland, Yves, MD, PhD</creatorcontrib><creatorcontrib>Dupuy, Charlotte, PhD</creatorcontrib><creatorcontrib>Abellan Van Kan, Gabor, MD, PhD</creatorcontrib><creatorcontrib>Cesari, Matteo, MD, PhD</creatorcontrib><creatorcontrib>Vellas, Bruno, MD, PhD</creatorcontrib><creatorcontrib>Faruch, Marie, MD</creatorcontrib><creatorcontrib>Dray, Cedric, MD, PhD</creatorcontrib><creatorcontrib>de Souto Barreto, Philipe, PhD</creatorcontrib><title>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</title><title>Journal of the American Medical Directors Association</title><addtitle>J Am Med Dir Assoc</addtitle><description>Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Geriatric Assessment</subject><subject>Hand Strength</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical Education</subject><subject>physical performances</subject><subject>SARC-F</subject><subject>Sarcopenia</subject><subject>Sarcopenia - diagnosis</subject><subject>Sarcopenia - epidemiology</subject><subject>screening</subject><subject>Surveys and Questionnaires</subject><subject>Walking Speed</subject><issn>1525-8610</issn><issn>1538-9375</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1DAUhSNERR_wC5CQl2wS_BjbCRJIo1EfSJUoBMTS8tg3qkMSD3aClH9fmyks2HTluzjnHp_vFsVrgiuCiXjXV70era4oJrLCvMIEPyvOCGd12TDJn-eZ8rIWBJ8W5zH2GCdpI14Up7QWtJFEnhWx1cH4A0xOo9YEgAks2q9ovgfUbr_uyiv0ZYE4Oz9N2gVAerLo7n6NzugB3UHofBj1ZCAi36HLwUIYVvTDjzC9R1u0Cz7GsgWTFyRDOy92fVmcdHqI8OrxvSi-X11-292Ut5-vP-22t6XZ1HguDeaNYEzTuu5EzQ0HYTnjrOm6De5qSwVIJsieYQFUEttJymq9x1QLwxtg7KJ4e9x7CP5XLqFGFw0Mg57AL1GRhhCJyYZlKTtKTf5wgE4dght1WBXBKtNWvfpDW2XaCnOVaCfXm8eAZT-C_ef5izcJPhwFkGr-dhBUNA4SLZtQmllZ754I-Pif3wxuyuh_wgqx90tIVFMTFanCqs0Hz_dO0ZhKydgDa3WlSw</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Rolland, Yves, MD, PhD</creator><creator>Dupuy, Charlotte, PhD</creator><creator>Abellan Van Kan, Gabor, MD, PhD</creator><creator>Cesari, Matteo, MD, PhD</creator><creator>Vellas, Bruno, MD, PhD</creator><creator>Faruch, Marie, MD</creator><creator>Dray, Cedric, MD, PhD</creator><creator>de Souto Barreto, Philipe, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20171001</creationdate><title>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</title><author>Rolland, Yves, MD, PhD ; Dupuy, Charlotte, PhD ; Abellan Van Kan, Gabor, MD, PhD ; Cesari, Matteo, MD, PhD ; Vellas, Bruno, MD, PhD ; Faruch, Marie, MD ; Dray, Cedric, MD, PhD ; de Souto Barreto, Philipe, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-c059633a288f685c5e6d53539ff40f8d26e7361b306e271df7238ab02a6c59e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Geriatric Assessment</topic><topic>Hand Strength</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical Education</topic><topic>physical performances</topic><topic>SARC-F</topic><topic>Sarcopenia</topic><topic>Sarcopenia - diagnosis</topic><topic>Sarcopenia - epidemiology</topic><topic>screening</topic><topic>Surveys and Questionnaires</topic><topic>Walking Speed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rolland, Yves, MD, PhD</creatorcontrib><creatorcontrib>Dupuy, Charlotte, PhD</creatorcontrib><creatorcontrib>Abellan Van Kan, Gabor, MD, PhD</creatorcontrib><creatorcontrib>Cesari, Matteo, MD, PhD</creatorcontrib><creatorcontrib>Vellas, Bruno, MD, PhD</creatorcontrib><creatorcontrib>Faruch, Marie, MD</creatorcontrib><creatorcontrib>Dray, Cedric, MD, PhD</creatorcontrib><creatorcontrib>de Souto Barreto, Philipe, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Medical Directors Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rolland, Yves, MD, PhD</au><au>Dupuy, Charlotte, PhD</au><au>Abellan Van Kan, Gabor, MD, PhD</au><au>Cesari, Matteo, MD, PhD</au><au>Vellas, Bruno, MD, PhD</au><au>Faruch, Marie, MD</au><au>Dray, Cedric, MD, PhD</au><au>de Souto Barreto, Philipe, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study</atitle><jtitle>Journal of the American Medical Directors Association</jtitle><addtitle>J Am Med Dir Assoc</addtitle><date>2017-10-01</date><risdate>2017</risdate><volume>18</volume><issue>10</issue><spage>848</spage><epage>852</epage><pages>848-852</pages><issn>1525-8610</issn><eissn>1538-9375</eissn><abstract>Abstract Objectives Screening for sarcopenia in daily practice can be challenging. Our objective was to explore whether the SARC-F questionnaire is a valid screening tool for sarcopenia (defined by the Foundation for the National Institutes of Health [FNIH] criteria). Moreover, we evaluated the physical performance of older women according to the SARC-F questionnaire. Design Cross-sectional study. Participants Data from the Toulouse and Lyon EPIDémiologie de l’OStéoporose study (EPIDOS) on 3025 women living in the community (mean age: 80.5 ± 3.9 years), without a previous history of hip fracture, were assessed. Measurements The SARC-F self-report questionnaire score ranges from 0 to 10: a score ≥4 defines sarcopenia. The FNIH criteria uses handgrip strength (GS) and appendicular lean mass (ALM; assessed by DXA) divided by body mass index (BMI) to define sarcopenia. Outcome measures were the following performance-based tests: knee-extension strength, 6-m gait speed, and a repeated chair-stand test. The associations of sarcopenia with performance-based tests was examined using bootstrap multiple linear-regression models; adjusted R2 determined the percentage variation for each outcome explained by the model. Results Prevalence of sarcopenia was 16.7% (n = 504) according to the SARC-F questionnaire and 1.8% (n = 49) using the FNIH criteria. Sensibility and specificity of the SARC-F to diagnose sarcopenia (defined by FNIH criteria) were 34% and 85%, respectively. Sarcopenic women defined by SARC-F had significantly lower physical performance than nonsarcopenic women. The SARC-F improved the ability to predict poor physical performance. Conclusion The validity of the SARC-F questionnaire to screen for sarcopenia, when compared with the FNIH criteria, was limited. However, sarcopenia defined by the SARC-F questionnaire substantially improved the predictive value of clinical characteristics of patients to predict poor physical performance.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28629717</pmid><doi>10.1016/j.jamda.2017.05.010</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1525-8610
ispartof Journal of the American Medical Directors Association, 2017-10, Vol.18 (10), p.848-852
issn 1525-8610
1538-9375
language eng
recordid cdi_proquest_miscellaneous_1911701433
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Aged
Aged, 80 and over
Cross-Sectional Studies
Female
France - epidemiology
Geriatric Assessment
Hand Strength
Humans
Internal Medicine
Medical Education
physical performances
SARC-F
Sarcopenia
Sarcopenia - diagnosis
Sarcopenia - epidemiology
screening
Surveys and Questionnaires
Walking Speed
title Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T01%3A39%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sarcopenia%20Screened%20by%20the%20SARC-F%20Questionnaire%20and%20Physical%20Performances%20of%20Elderly%20Women:%20A%20Cross-Sectional%20Study&rft.jtitle=Journal%20of%20the%20American%20Medical%20Directors%20Association&rft.au=Rolland,%20Yves,%20MD,%20PhD&rft.date=2017-10-01&rft.volume=18&rft.issue=10&rft.spage=848&rft.epage=852&rft.pages=848-852&rft.issn=1525-8610&rft.eissn=1538-9375&rft_id=info:doi/10.1016/j.jamda.2017.05.010&rft_dat=%3Cproquest_cross%3E1911701433%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1911701433&rft_id=info:pmid/28629717&rft_els_id=S1525861017302773&rfr_iscdi=true